Oncology
Conditions
Brief summary
This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (\> 70 years) adults with cancer.
Detailed description
This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (\> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results. This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.
Interventions
OTHERResults of the brief geriatric assessment
Providers will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
OTHERNo results of brief geriatric assessments
Providers will not receive results of the brief geriatric assessment. Participants will receive standard of care treatment
Sponsors
UNC Lineberger Comprehensive Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
This is an un-blinded, 2-arm randomized control trial of a brief, user friendly GA report in real time which summarizes GA-identified deficits and includes recommendations for evidence informed multidisciplinary interventions to address these deficits.
Eligibility
Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 70 years or older. * English speaking. * Admitted to UNC Hospitals non-electively within 72 hours. * Biopsy proven solid tumor or myeloma or lymphoma. * Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months. * Signed written IRB-approved informed consent.
Exclusion criteria
* Patients meeting any of the following
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Referral rate for GA-identified deficits in intervention and control groups | 2 years | Number of participants with at least one referral for a GA-idenfied deficit |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Referral to Geriatic Consultation | 2 years | Number of times a Geriatric Consultation referral was given in Intervention and Control group |
| Referral to Clinical Pharmacist | 2 years | Number of times Clinical Pharmacist referral was given in Intervention and Control group |
| Referral to Nutritionist | 2 years | Number of times Nutritionist referral was given in Intervention and Control group |
| Referral to Physical and Occupational therapy | 2 years | Number of times physical and occupation therapy referral was given in Intervention and Control group |
| Physician Reported New information | 2 years | Number of times physicians answer yes to the questions did report provide new information about patient deficits that would warrant a referral |
| Physician Reported Satisfaction | 2 years | Number of times physician indicate yes report was helpful when asked Is this report useful |
| Referral to psyhcosocial support team | 2 years | Number of times psychosocial support referral was given in Intervention and Control group |
Countries
United States
Outcome results
None listed